In Rthe resulting unique failure immunotherapy killed a patient receiving treatment for cancer. 20-year-old young man died after this kind of treatment triggered a fatal relapse of malignant neoplasms.
The Nobel prize in physiology or medicine this year received the American and Japanese scientists involved in the possibilities of immunotherapy in the treatment of cancer. Experts call this trend in Oncology is the most promising, because with the help of drugs based on monoclonal antibodies, training the immune system to find the tumor, it is possible to resist and even win is incurable cases of cancer. However, immunotherapy is not without certain side effects, and tells the story of 20-year-old American patient who died because of this type of treatment.
In fairness, it should immediately be noted that in the scientific world yet other stories, describing the death of the patient from immunotherapy, so that this case can be considered incredibly rare. The young man, whose name was not called, had received immunotherapy for the treatment of highly aggressive forms of leukemia – cancer of the immune system, called acute lymphoblastic leukemia. The therapy was genetically trained his immune cells to attack and destroy the tumor.
Unfortunately, for some reason cancer cells as a result of this kind of treatment received, that is, turbosketch and not only escaped death but have begun to multiply in the body with frightening speed and with fatal consequences. As a result, young people quickly died. Although this case is only in the history of immunotherapy, scientists emphasize that he suggests that this technique still has much to improve in terms of security. (READ MORE)